describe the image

"When looking at NPRM for Stage 2 MU, it is important to remember that differences between the NPRM for Meaningful Use Stage 1 and the Final Rule were sometimes significant."

Considering the Impact of Proposed Stage 2 Meaningful Use Changes

John Moquin, Beacon Partners Executive Consultant, explains the impact that the proposed Meaningful Use Stage 2 requirements could have on your organization and how to avoid costly and time-consuming adjustments down the road.

This article highlights:

  • A high-level summary of the affected objectives
  • Changes to Clinical Quality Measures (CQMs) reporting requirements
  • How to prepare for impact

Complete the form below to read the Beacon Partners article: